Methyl (1RS, 3RS)-cis-1-butyl-3-hydroxymethyl-1,2,3,4-tetrahydro-beta-carboline-2-carbodithioate | 96086-32-7

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: Methyl (1RS, 3RS)-cis-1-butyl-3-hydroxymethyl-1,2,3,4-tetrahydro-beta-carboline-2-carbodithioate
• 英文别名: methyl (1S,3S)-1-butyl-3-(hydroxymethyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbodithioate
• CAS: 96086-32-7；96086-33-8
• 化学式: C₁₈H₂₄N₂OS₂
• 分子量: 348.533
• InChiKey: PKKSTQADAITZPN-LRDDRELGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  96.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  methyl (1S,3S)-1-butyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate 在 sodium tetrahydroborate 、 三乙胺 作用下， 以 乙醇 为溶剂， 反应 15.0h， 生成 Methyl (1RS, 3RS)-cis-1-butyl-3-hydroxymethyl-1,2,3,4-tetrahydro-beta-carboline-2-carbodithioate
  参考文献：
  名称：

  Synthesis of 1,2,3,4-tetrahydro-.BETA.-carboline derivatives as hepatoprotective agents. IV. Positional isomers of 1,2,3,4-tetrahydro-2-methylthiothiocarbonyl-.BETA.-carboline-3-carboxylic acid and its 1-alkylated derivatives.

  摘要：

  合成了两种四氢-β-咔啉-1和-4-羧酸（1b，c）及相应的羟甲基衍生物（2b，c），它们是3-羧酸（1a）及其3-羟甲基衍生物（2a）的位置异构体，并测试了它们对四氯化碳（CCl4）诱导的小鼠肝损伤的保肝活性。这些位置异构体的保肝活性依次降低：1a>1b>1c>和2a>2b>2c。顺式和反式异构体（5a、b-14a、b）也检测了 1a 和 2a 1 位上烷基取代的影响。带有小烷基（如 Me 和 Et）的化合物显示出强大的活性。烷基加长一般会导致活性降低。在一系列 3-羧酸立体异构体（5a、b-9a、b）中，顺式异构体的活性往往高于反式异构体。

  DOI：

  10.1248/cpb.35.3705

文献信息

• Tetrahydro-.beta.-carboline dithioic acid derivatives and treatment of
  申请人：Tanabe Seiyaku Co., Ltd.

  公开号：US04612317A1

  公开（公告）日：1986-09-16

  Tetrahydro-.beta.-carboline derivatives of the formula: ##STR1## wherein R.sup.1 is hydrogen atom, a lower alkyl group, a cycloalkyl group, phenyl group or a hydroxy-substituted lower alkyl group, R.sup.2 is hydrogen atom, an alkyl group, or a group of the formula: --(CH.sub.2).sub.m Y, Y is thienyl or a substituted or unsubstituted phenyl group, and m and n are an integer of 1 or 2, which have excellent alleviating, curing and preventing hepatic damages and are useful as a therapeutic or prophylactic agent for hepatic diseases, and a process for the preparation of said compounds.

  公式为：##STR1## 的四氢-β-咔啉衍生物，其中R.sup.1是氢原子，较低的烷基，环烷基，苯基或羟基取代的较低烷基，R.sup.2是氢原子，烷基或公式的基团：--（CH.sub.2）.sub.m Y，Y是噻吩基或取代或未取代的苯基团，m和n是1或2的整数，具有优异的缓解，治愈和预防肝损伤的作用，并且作为治疗或预防肝病的治疗药物或预防药物的制备方法。
• Synthesis of 1,2,3,4-tetrahydro-.BETA.-carboline derivatives as hepatoprotective agents. IV. Positional isomers of 1,2,3,4-tetrahydro-2-methylthiothiocarbonyl-.BETA.-carboline-3-carboxylic acid and its 1-alkylated derivatives.
  作者：YUTAKA SAIGA、IKUO IIJIMA、AKIHIKO ISHIDA、TOSHIKAZU MIYAGISHIMA、NORIO TAKAMURA、TOKURO OH-ISHI、MAMORU MATSUMOTO、Yuzo MATSUOKA

  DOI：10.1248/cpb.35.3705

  日期：——

  Two tetrahydro-β-carboline-1-and-4-carboxylic acids (1b, c) and the corresponding hydroxymethyl derivatives (2b, c), which are positional isomers of the 3-carboxylic acid (1a) and its 3-hydroxymethyl derivative (2a), were synthesized and tested for hepatoprotective activity against carbon tetrachloride (CCl4) -induced liver damage in mice. The hepatoprotective activity of these positional isomers decreased in the following order;1a> 1b> 1c> and 2a > 2b>2c. The effect of alkyl substitution at the 1 position of 1a and 2a was also examined with the cis and trans isomers (5a, b-14a, b). Compounds with small alkyl groups such as Me and Et showed potent activity. Lengthening of the alkyl group generally caused a decrease in activity. In a series of the stereoisomers of the 3-carboxylic acids (5a, b-9a, b), the cis isomers tend to be more active than the trans counterparts.

  合成了两种四氢-β-咔啉-1和-4-羧酸（1b，c）及相应的羟甲基衍生物（2b，c），它们是3-羧酸（1a）及其3-羟甲基衍生物（2a）的位置异构体，并测试了它们对四氯化碳（CCl4）诱导的小鼠肝损伤的保肝活性。这些位置异构体的保肝活性依次降低：1a>1b>1c>和2a>2b>2c。顺式和反式异构体（5a、b-14a、b）也检测了 1a 和 2a 1 位上烷基取代的影响。带有小烷基（如 Me 和 Et）的化合物显示出强大的活性。烷基加长一般会导致活性降低。在一系列 3-羧酸立体异构体（5a、b-9a、b）中，顺式异构体的活性往往高于反式异构体。